Galera Therapeutics, Inc. (GRTX) Income Tax Expense (Benefit) USD 2018 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Galera Therapeutics, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from 2018 to 2023.
  • Galera Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2018 was -$52 K.
  • Galera Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000, a 100% decline from 2022.
  • Galera Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $70 K.
  • Galera Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 -$70 K -100% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $70 K +$70 K Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $0 +$16 K Jan 1, 2021 Dec 31, 2021 10-K 2023-03-08
2020 -$16 K -$7 K -77.8% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 -$9 K +$214 K +96% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 -$223 K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.